Paul Cohen


  • The University of Western Australia (M550), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


Career Summary

Paul Cohen is a Consultant at The Western Australian Gynaecological Cancer Service at King Edward Memorial Hospital; Clinical Professor in the Division of Obstetrics and Gynaecology, Medical School, The University of Western Australia; and Adjunct Professor at the Institute for Health Research, University of Notre Dame Australia, Fremantle. Paul graduated with a degree in Physiological Sciences from Oxford University in 1997 and completed his medical training at Oxford in 2000. He moved to New Zealand in 2001 and completed specialist training in Obstetrics and Gynaecology at National Womens Hospital in Auckland. Paul undertook full time research in the molecular biology of ovarian granulosa cell tumours and was awarded a Doctorate in Medicine by the University of Auckland in 2010. He moved to Australia in 2010 to undertake a three-year clinical fellowship in gynaecological oncology and has been based in Perth, Western Australia since 2013.

Profile and Peer Recognition

Paul is the current Chair of the International Gynecological Cancer Society (IGCS) Education Committee, an IGCS Board member, Chair of the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) Research Advisory Committee and a Director of ANZGOG. He is a member of the Australian eviQ National Guidelines Cancer Genetics Reference Committee and the Australian Clinical Trial Alliance Impact and Implementation Committee.

Paul has served on Scientific Committees for the 17th Biennial Meeting of the IGCS, Kyoto, Japan 2018, the 2021 IGCS Annual Global Meeting, the European Society of Medical Oncology (ESMO) Asia Congress Gynaecological Cancers track, Singapore, 2022, and chaired the ANZGOG Annual Scientific Meeting Program Committee from 2018 to 2021.

Paul is a member of the Steering Committee of the Australian National Gynaecological Oncology Registry (NGOR), NGOR Ovarian Cancer Working Group, Ovarian Tumour Tissue Analysis (OTTA) Consortium, and the Editorial Board of the International Journal of Gynecological Cancer. He is a reviewer for journals including the Lancet and the Lancet Oncology and was presented with awards by the International Journal of Gynecological Cancer for Top Editorial Board Member in 2019 and Top Reviewer in 2021.


Paul has been actively involved in teaching 3rd year medical students at UWA and King Edward Memorial Hospital since 2013. He is a mentor for Year 3 clinical students and regularly gives lectures. He has been an Examiner in the Medical Student OSCE since 2014 and regularly teaches and assess medical students in a clinical setting. He has supervised four PhD students, two Masters’ students and three MD students.


Paul’s research focus is on improving outcomes and quality of life for survivors of gynaecological cancer. He is the Principal Investigator of a prospective national clinical trial "Getting the MOST out of follow-up: a randomised controlled trial to compare three-monthly nurse-led telephone follow-up, including monitoring serum CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic-based follow-up, following completion of first-line chemotherapy in patients with epithelial ovarian cancer" (ACTRN12620000332921) funded by the WA Health Translation Network, the Medical Research Future Fund and ANZGOG.

He is a Chief Investigator on "Ovarian cancer: investigating Variation in care and survival, Aetiology and Risk factors to Improve outcomes in Australia via National data linkage: the OVARIAN study" and the ADELE study, "ADjuvant Tislelizumab plus chemotherapy after post-operative pelvic chemoradiation in high-risk EndometriaL cancer", funded by the Medical Research Future Fund.

Paul is the Australian Principal Investigator of an ANZGOG funded international randomised clinical trial "STRatIfication of Vulvar squamous cell carcinoma by HPV and p53 status to guide Excision: the STRIVE study" and an investigator and steering committee member of two Western Australian studies ‘Enabling advanced single cell cancer genomics in Western Australia’ (PI Professor Alistair Forrest, UWA) and 'Continuous Improvement in Care Cancer - CIC Cancer (PI Professor Christobel Saunders, UWA) both funded by the Cancer Research Trust.

Paul was the lead investigator of an international collaboration that involved 16 sites in 11 countries that enabled an individual patient meta-analysis that showed the pathological chemotherapy response score (CRS) predicts survival in patients with advanced ovarian cancer receiving neoadjuvant chemotherapy. The score identifies the roughly one-third of all patients who show significantly improved progression-free survival and overall survival and has potential for incorporation into routine practice and clinical trial design as an early endpoint. This work led to the incorporation of the CRS into the 2019 joint European Society for Medical Oncology and European Society of Gynaecological Oncology consensus conference recommendations on ovarian cancer. 

He has published more than 120 scientific papers in peer-reviewed journals.

Community Engagement

Paul conceived and organised Western Australia’s inaugural Familial Breast and Ovarian Cancer Information Day held in May 2016, which was attended by more than 140 BRCA mutation carriers and their families, and the subsequent Familial Breast and Ovarian Cancer Information Days in 2017, 2019, 2021, and 2023. He is a regular speaker at Ovarian Cancer Australia support group meetings, Cancer Council Western Australia Education events, ANZGOG Public Forums, and facilitated the inaugural Western Australian ANZGOG ‘Survivors Teaching Students’ in Western Australia in 2019. 



Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Doctor of Medicine, MD, The Role of Oestrogen Receptor Beta in Ovarian Granulosa Cell Tumours, University of Auckland

Dec 2008Oct 2010

Award Date: 15 Nov 2010

Physiological Sciences, MA, University of Oxford

Oct 1994Jul 2000

Award Date: 1 Jul 2001

Medicine, BM BCh, University of Oxford

Aug 1997Jul 2000

Award Date: 1 Jul 2000

Physiological Sciences, BA, University of Oxford

Oct 1994Jul 1997

Award Date: 1 Jul 1997

External positions

Adjunct Professor, University of Notre Dame (Australia)

31 Oct 2015 → …

Research expertise keywords

  • Gynaecological Cancers
  • Cancer epidemiology
  • Survivorship in cancer
  • Cancer genetics


Dive into the research topics where Paul Cohen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or